tetano
Editor, Senior Moderator
Inflammopharmacology
. 2023 Apr 20.
doi: 10.1007/s10787-023-01215-y. Online ahead of print.
Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients' susceptibility to COVID-19 to the possible caution of future global diabetes tsunami
Yasamin Sharbatdar[SUP] #[/SUP][SUP] 1 [/SUP], Ronak Mousavian[SUP] #[/SUP][SUP] 2 [/SUP], Seyed Mostafa Noorbakhsh Varnosfaderani[SUP] 3 [/SUP], Fatemeh Aziziyan[SUP] 4 5 [/SUP], Mahsa Liaghat[SUP] 5 6 [/SUP], Payam Baziyar[SUP] 7 [/SUP], Ali Yousefi Rad[SUP] 8 [/SUP], Chanour Tavakol[SUP] 9 [/SUP], Amir Mansour Moeini[SUP] 10 [/SUP], Mohsen Nabi-Afjadi[SUP] 11 [/SUP], Hamidreza Zalpoor[SUP] 12 13 [/SUP], Fatemeh Kazemi-Lomedasht[SUP] 14 [/SUP]
Affiliations
Abstract
According to recent researches, people with diabetes mellitus (type 1 and 2) have a higher incidence of coronavirus disease 2019 (COVID-19), which is caused by a SARS-CoV-2 infection. In this regard, COVID-19 may make diabetic patients more sensitive to hyperglycemia by modifying the immunological and inflammatory responses and increasing reactive oxygen species (ROS) predisposing the patients to severe COVID-19 and potentially lethal results. Actually, in addition to COVID-19, diabetic patients have been demonstrated to have abnormally high levels of inflammatory cytokines, increased virus entrance, and decreased immune response. On the other hand, during the severe stage of COVID-19, the SARS-CoV-2-infected patients have lymphopenia and inflammatory cytokine storms that cause damage to several body organs such as β cells of the pancreas which may make them as future diabetic candidates. In this line, the nuclear factor kappa B (NF-κB) pathway, which is activated by a number of mediators, plays a substantial part in cytokine storms through various pathways. In this pathway, some polymorphisms also make the individuals more competent to diabetes via infection with SARS-CoV-2. On the other hand, during hospitalization of SARS-CoV-2-infected patients, the use of some drugs may unintentionally lead to diabetes in the future via increasing inflammation and stress oxidative. Thus, in this review, we will first explain why diabetic patients are more susceptible to COVID-19. Second, we will warn about a future global diabetes tsunami via the SARS-CoV-2 as one of its long-term complications.
Keywords: COVID-19; Diabetes; Lymphopenia; NF-κB pathway; SARS-CoV-2; Stress oxidative.
. 2023 Apr 20.
doi: 10.1007/s10787-023-01215-y. Online ahead of print.
Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients' susceptibility to COVID-19 to the possible caution of future global diabetes tsunami
Yasamin Sharbatdar[SUP] #[/SUP][SUP] 1 [/SUP], Ronak Mousavian[SUP] #[/SUP][SUP] 2 [/SUP], Seyed Mostafa Noorbakhsh Varnosfaderani[SUP] 3 [/SUP], Fatemeh Aziziyan[SUP] 4 5 [/SUP], Mahsa Liaghat[SUP] 5 6 [/SUP], Payam Baziyar[SUP] 7 [/SUP], Ali Yousefi Rad[SUP] 8 [/SUP], Chanour Tavakol[SUP] 9 [/SUP], Amir Mansour Moeini[SUP] 10 [/SUP], Mohsen Nabi-Afjadi[SUP] 11 [/SUP], Hamidreza Zalpoor[SUP] 12 13 [/SUP], Fatemeh Kazemi-Lomedasht[SUP] 14 [/SUP]
Affiliations
- PMID: 37079169
- DOI: 10.1007/s10787-023-01215-y
Abstract
According to recent researches, people with diabetes mellitus (type 1 and 2) have a higher incidence of coronavirus disease 2019 (COVID-19), which is caused by a SARS-CoV-2 infection. In this regard, COVID-19 may make diabetic patients more sensitive to hyperglycemia by modifying the immunological and inflammatory responses and increasing reactive oxygen species (ROS) predisposing the patients to severe COVID-19 and potentially lethal results. Actually, in addition to COVID-19, diabetic patients have been demonstrated to have abnormally high levels of inflammatory cytokines, increased virus entrance, and decreased immune response. On the other hand, during the severe stage of COVID-19, the SARS-CoV-2-infected patients have lymphopenia and inflammatory cytokine storms that cause damage to several body organs such as β cells of the pancreas which may make them as future diabetic candidates. In this line, the nuclear factor kappa B (NF-κB) pathway, which is activated by a number of mediators, plays a substantial part in cytokine storms through various pathways. In this pathway, some polymorphisms also make the individuals more competent to diabetes via infection with SARS-CoV-2. On the other hand, during hospitalization of SARS-CoV-2-infected patients, the use of some drugs may unintentionally lead to diabetes in the future via increasing inflammation and stress oxidative. Thus, in this review, we will first explain why diabetic patients are more susceptible to COVID-19. Second, we will warn about a future global diabetes tsunami via the SARS-CoV-2 as one of its long-term complications.
Keywords: COVID-19; Diabetes; Lymphopenia; NF-κB pathway; SARS-CoV-2; Stress oxidative.